Pacific Biosciences Of California (PACB)

CapEx to Revenue

11.79%

Quarterly · Period ending:

PACB logo

PACB CapEx to Revenue

Latest reported11.79%
PACB Quarterly CapEx/Revenue (0.00% → 11.79%)
High-resolution chart · PNG

PACB capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacific Biosciences Of California CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
11.7876%
8.1849%
1.9285%
0.2237%
1.3831%
17.1965%
4.1225%
1.9691%
4.1069%
9.9948%
3.4683%
1.4904%
4.7674%
9.5656%
18.583%
12.9646%
11.3317%
10.9668%
7.8903%
3.2075%
5.1258%
1.3829%
0.2469%
2.8089%
1.868%
0.7501%
0.5048%
3.7828%
2.4897%
7.6286%
0.297%
0.5286%
6.2842%
1.7767%
4.2511%
13.8331%
17.1773%
10.7084%
10.3064%
9.1608%
13.4863%
2.3893%
2.42%
3.2981%
3.8293%
4.0635%
2.8218%
0.9213%
4.07%
4.0972%
1.1167%
3.0993%
4.6296%
5.3245%
7.4855%
17.3631%
6.9538%
2.7296%
11.5558%
21.4659%
38.4948%
554.0741%
438.9286%
471.8182%
286.0095%
218.8991%
2,675.5556%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.